Novartis Targets Oncology Leadership with $1.5B Acquisition of ADC Innovator Myricx Bio
In a significant move to reshape the future of precision oncology, pharmaceutical giant Novartis has announced a definitive agreement to...
In a significant move to reshape the future of precision oncology, pharmaceutical giant Novartis has announced a definitive agreement to...
For over four decades, the Human Immunodeficiency Virus (HIV) has remained one of the most formidable adversaries in the history...
The landscape of genome editing has been defined by the rapid ascent of CRISPR-Cas9, a tool that transformed molecular biology...
As the global scientific community gathers in Montreal for the International Society for Stem Cell Research (ISSCR) 2026 meeting from...
Over the past decade, the human microbiome has undergone a radical transformation in the eyes of the scientific community. Once...
In a pioneering study that blurs the lines between cancer immunotherapy and allergy treatment, researchers at Lausanne University Hospital and...
In the landscape of modern science fiction, few characters have captured the collective imagination of the "maker" community quite like...
In the high-stakes world of biotechnology, investor sentiment can pivot on a single data point. For Paris-based Abivax (Euronext Paris...
The medical landscape was irrevocably altered by the success of "Baby KJ," the first patient to undergo a pioneering, personalized...
In a landmark study published in Nature Materials, researchers at the European Molecular Biology Laboratory (EMBL) have unveiled a fundamental...
The 74th American Society for Mass Spectrometry (ASMS) Conference, held in the sun-drenched innovation hub of San Diego, served as...
The biotechnology sector is currently experiencing a profound period of transformation, characterized by aggressive strategic consolidation, the maturation of artificial...